ARCHIVES

Dasatinib, Nilotinib Show Strong Early Results As Frontline Therapy For CML

This article is from The Cancer Letter archive.

Vol. 30 No. 12 | December 28, 2007

Download PDF Visit The Full Archive

Related Articles

Screening Mammograms In Young Women Have Low Accuracy, Detect Few Cancers

May 28, 2010

Avastin-Zybrestat Combination Increases Progression-Free Survival in Phase II Trial

March 28, 2014

In Brief CCOP Prospects Submit 130 Letters Of Intent; DeVita recovering On Schedule from Surgery

September 26, 1986

New SEER RFP Sees cheaper Way To Get Data

July 29, 1977

Cancer Research Faces A “Strategic Inflection,” NCI Director Says

April 19, 2002

Program Announcement; NCI Seeks Studies Of Breast Cancer In Northeast U.S.

January 22, 1993